Aerial Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aerial biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aerial Biopharma Today - Breaking & Trending Today

Axsome Therapeutics: All Eyes On Auvelity Launch

Shares of Axsome Therapeutics have posted a 30% gain so far in 2022. Read more to understand why this stock needs to be watched. ....

New York , United States , Mark Coleman , Roger Jeffs , Mark Saad , Eli Lilly , Mark Jacobson , Nick Pizzie , Ladenburg Thalmann , Jazz Pharmaceuticals , Corporate Development At Stemline Therapeutics , Business Development Lori Englebert , Supernus Pharmaceuticals , Health Sciences , Therapist Meeting , Axsome Therapeutics , Core Biotech , Wall Street , Corporate Slides , Breakthrough Therapy Designation , European Sunosi , Complete Response Letter , Aerial Biopharma , Sunosi Investor Event , Adage Capital Partners , Funds Management ,

Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics

Under the terms of the agreement, Jazz received an upfront payment of $53 million, and will receive a high single-digit royalty on Axsome's U.S. net sales of Sunosi in current indications and a mid-single-digit royalty on Axsome's U.S. net sales of Sunosi in future indications. Subject to the satisfaction of . ....

United States , Bruce Cozadd , Sk Biopharmaceuticals Co Ltd , Axsome Therapeutics Inc , Aerial Biopharma , Jazz Pharmaceuticals , Drug Administration , Us Drug Enforcement Agency , Axsome Therapeutics , Enforcement Agency , Safety Information ,

Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has completed the divestiture of Sunosi® (solriamfetol) in the U.S. to Axsome. ....

United States , Kristin Bhavnani , Andrean Flynn , Bruce Cozadd , Sk Biopharmaceuticals Co Ltd , Axsome Therapeutics Inc , Aerial Biopharma , Jazz Pharmaceuticals , Drug Administration , Head Of Global Corporate Communications , Exchange Commission , Prnewswire Jazz Pharmaceuticals , Us Drug Enforcement Agency On , Axsome Therapeutics , Enforcement Agency , Safety Information , Annual Report , Global Corporate , Jazz Pharmaceuticals Plc ,

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi (solriamfetol) to Axsome Therapeutics

DUBLIN, May 9, 2022 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has completed the divestiture of Sunosi (solriamfetol) in the U.S. to Axsome Therapeutics ....

United States , Kristin Bhavnani , Andrean Flynn , Bruce Cozadd , Sk Biopharmaceuticals Co Ltd , Axsome Therapeutics Inc , Aerial Biopharma , Jazz Pharmaceuticals , Drug Administration , Head Of Global Corporate Communications , Exchange Commission , Prnewswire Jazz Pharmaceuticals , Us Drug Enforcement Agency On , Axsome Therapeutics , Enforcement Agency , Safety Information , Annual Report , Global Corporate ,

Axsome Therapeutics to Acquire Sunosi from Jazz Pharmaceuticals

The acquisition of Sunosi adds a high-potential commercial asset to Axsome’s late-stage neuroscience portfolio. ....

United States , Herriot Tabuteau , Bruce Cozadd , Symphony Health Data , Axsome Therapeutics Inc , European Medicines Agency , Jazz Pharmaceuticals , Drug Administration , Hercules Capital Inc , Digital Centric Commercialization , High Potential Commercial Asset , Late Stage Neuroscience , Therapeutic Focus , Deliver Substantial Shareholder , Aerial Biopharma , Hercules Capital , Hart Scott Rodino Antitrust Improvements Act ,